Transporting a donor organ is a race against biology. From the moment an organ is removed from a donor, it begins to deteriorate, and the entire chain of packaging, preservation, and logistics exists to slow that damage and get the organ to a recipient as quickly as possible. The process involves specialized preservation fluids, carefully controlled temperatures, coordinated air and ground transport, and a growing set of technologies designed to keep organs viable over longer distances.
Why Time Matters: The Ischemia Clock
Once an organ loses its blood supply during recovery from the donor, cells begin starving for oxygen. This period, called cold ischemia time, is the central constraint of the entire transport process. Different organs tolerate this differently. Hearts and lungs are the most fragile, generally needing to reach the recipient within 4 to 6 hours. Livers can last roughly 8 to 12 hours. Kidneys are the most resilient, routinely transported over 16 to 24 hours, and research has shown that even kidneys with cold ischemia times exceeding 32 or 40 hours can function well after transplantation, particularly when the donor organ is otherwise healthy.
These windows aren’t hard cutoffs. They’re risk gradients: the longer an organ sits without blood flow, the higher the chance of delayed function or damage after transplant. Every decision in the transport chain, from which preservation method to use to whether the organ flies by charter jet or helicopter, is ultimately about compressing this timeline.
Preservation: Keeping the Organ Alive Outside the Body
The simplest and most common method is static cold storage. The organ is flushed with a cold preservation solution, sealed in sterile bags, and placed in an insulated cooler packed with ice. The target temperature is 4 to 8°C. Hypothermia slows the organ’s metabolism to a crawl, reducing its demand for oxygen and nutrients. Straying outside that range in either direction, whether the organ freezes or warms too much, damages the cells and shortens viability.
Two preservation solutions dominate the field. University of Wisconsin (UW) solution has been the gold standard since 1987, especially for liver transplants. It contains a high concentration of potassium and a starch compound that helps prevent cell swelling. The alternative, HTK solution (named for its three key ingredients: histidine, tryptophan, and ketoglutarate), has a lower viscosity, which means it flows more easily through the organ’s blood vessels during the initial flush. This can cool the organ faster and wash out residual blood more completely. HTK is also less expensive.
For kidneys specifically, a more advanced option called hypothermic machine perfusion has proven superior to simply sitting on ice. Instead of static storage, a portable pump continuously circulates cold preservation fluid through the kidney during transport. A large Cochrane review found high-certainty evidence that machine perfusion reduces the risk of delayed graft function, where the recipient needs dialysis in the first week after transplant, by about 23% compared to static cold storage. For every 7 to 14 kidneys placed on a pump instead of ice, one episode of post-transplant dialysis is prevented.
Warm Perfusion for Hearts and Livers
A newer approach flips the logic entirely. Normothermic machine perfusion keeps the organ at body temperature (37°C) and supplies it with oxygenated blood or a blood-based solution, essentially keeping it functioning outside the body. For livers, this means the organ continues producing bile and metabolizing nutrients during transport, which lets the transplant team assess its quality in real time rather than guessing based on donor characteristics alone. This technology is particularly valuable for organs from older donors or those with fatty liver disease, organs that might otherwise be discarded because they’re considered too risky for standard cold storage. Normothermic perfusion can also reveal bile duct injuries earlier than other clinical measures, giving surgeons better information before they commit to the transplant.
Packaging and Labeling
Organs are packaged in multiple sterile layers before going into a transport cooler. Federal policy through the Organ Procurement and Transplantation Network (OPTN) requires that all organ procurement organizations and transplant centers use standardized external, internal, and vessel labels distributed by the OPTN contractor. These labels are color-coded by organ type to reduce the risk of mix-ups, a critical safeguard when multiple organs from a single donor may be heading to different hospitals across the country simultaneously.
The cooler itself is a rigid, insulated container designed to maintain temperature for the duration of the trip. Sterile ice surrounds the bagged organ but never contacts it directly. The packaging must protect against physical shock, contamination, and temperature fluctuation during what can be a multi-leg journey involving ambulances, airports, and operating room hallways.
Getting From Donor to Recipient
The logistics of moving an organ across a city or across the country fall primarily to organ procurement organizations (OPOs), the regional nonprofits responsible for coordinating donation. The mode of transport depends on distance, urgency, and geography. Short distances of a few miles might involve a ground ambulance or even a police escort through traffic. Longer distances require air transport, either by commercial airline or charter flight.
OPOs in densely populated urban areas tend to use ground transport or short helicopter flights more often. Those covering large, geographically spread-out regions rely more heavily on commercial airlines and charter jets. Charter flights are faster and more controllable but far more expensive. Commercial flights are cheaper but subject to delays, cancellations, and the complications of navigating airport security with a cooler of human tissue. The Federal Aviation Administration has studied these challenges and noted that the organ transport system lacks a single standardized approach to air logistics.
One persistent problem has been tracking. Unlike a package from an online retailer, most organs in transit have historically lacked real-time GPS monitoring. UNOS has developed and launched its own organ tracking technology, currently used by 16 OPOs, and is advocating for federal regulators to mandate physical trackers on all unaccompanied deceased donor organs and build a centralized national tracking system. The goal is to eliminate the situation where a transplant team is waiting in an operating room with no reliable way to know exactly where the organ is or when it will arrive.
Drones: A New Transport Option
Unmanned aerial vehicles are moving from experimental curiosity to practical tool. In 2019, a custom-built drone carried a human kidney 2.8 miles across Baltimore to the University of Maryland Medical Center, completing the world’s first clinical drone organ delivery. The flight took about 10 minutes, and onboard sensors continuously monitored temperature, pressure, and vibration. The kidney was successfully transplanted.
Since then, milestones have come quickly. In 2021, a drone in Minnesota flew a human pancreas on a 10-mile loop over the Mississippi River; biopsies taken before and after the flight showed no tissue damage. In 2022, surgeons in Toronto completed the first drone delivery of a human lung, a 1.5-kilometer flight taking roughly 5 minutes, followed by a successful transplant in a patient with pulmonary fibrosis. International teams in Japan have demonstrated biochemical stability in drone-transported liver tissue over 12 kilometers.
Drones won’t replace jets for cross-country transport, but they could solve one of the most frustrating bottlenecks in organ logistics: the “last mile” through congested urban traffic between an airport and a hospital, or between two hospitals in the same city. A 10-minute drone flight can bypass a 45-minute ambulance ride through rush hour, and for a heart with only a few hours of viability, that difference can be decisive.
What Can Go Wrong
The transport phase introduces risks that don’t exist in the operating room. Temperature excursions are a constant concern. If ice melts faster than expected on a delayed flight, the organ warms past the safe range. If the cooler is stored too close to dry ice or in a freezing cargo hold, it can drop below 0°C and cause ice crystal damage to cells. Mechanical failure of perfusion pumps, airline delays, mislabeled containers, and communication breakdowns between OPOs and transplant centers have all contributed to organs arriving late or in compromised condition.
The system is improving. Standardized labeling, real-time tracking, machine perfusion, and drone delivery each address a specific failure point. But organ transport remains one of the most logistically complex and time-sensitive operations in medicine, where the margin for error is measured in hours and the consequence of failure is a life that could have been saved.